5 Minute Read – The “Green Rush”: Market exposure to the growing cannabis industry
V.E is constantly monitoring changes that impact the world of investing. Our analysts have put together a short briefing intended to keep you informed on the the latest in ESG.
In December 2020, the UN Commission on Narcotic Drugs reclassified cannabis out of the most dangerous category of drugs, thus recognising its medicinal potential. In the same month, the United States House of Representatives voted to effectively legalise recreational cannabis at the federal level.
This legislative and regulatory evolution has led to an increase of investment in the cannabis sector. In our newest #5MinuteRead – The “Green Rush”: Market exposure to the growing cannabis industry, Vigeo Eiris (V.E) summarises why cannabis production and use remain controversial and assesses how investors may be exposed to reputational risks.
LINK for the Paper is available below.
For more information on this briefing and V.E’s products & services, please contact:
Investor Customer Service
V.E is a global leader in ESG assessments, data, research, benchmarks and analytics. Leveraging our extensive proprietary database, we equip market players with the ESG insight they need to manage risks and better understand and address their social and environmental impact. Since 2019, V.E has been an Affiliate of Moody’s Corporation. V.E has an industry unique ISO 9001: 2015 quality certification for its processes relating to methodology, assessments, sale and delivery of its data to all types of investors and issuers. V.E is a Climate Bonds Initiative Verified Provider of Second Party Opinions. With a team of nearly 300 experts of 30 different nationalities, V.E is present in Paris, London, Brussels, Casablanca, Hong Kong, Milan, New York, Rabat and Santiago.For more information about V.E: vigeo-eiris.com
For more information about Moody’s ESG Solutions: moodys.com/esg
cannabis, Controversy, investors